BioNTech (BNTX) Earnings Date, Estimates & Call Transcripts $98.77 -1.87 (-1.86%) As of 12:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioNTech Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5Before Market OpensEstimatedActual EPS (Mar. 10) $1.08 Beat By $0.70 Consensus EPS (Mar. 10) $0.38 BioNTech released Q4 2024 earnings on March 10, 2025, reporting an EPS of $1.08, which topped the consensus estimate of $0.38 by $0.70. Quarterly revenue fell 19.5% year-over-year to $1.19 billion, below analysts' expectations of $1.24 billion. With a trailing EPS of -$3.00, BioNTech's earnings are expected to decrease next year, from ($3.88) to ($4.17) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by BNTX Upcoming EarningsBioNTech's next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get BioNTech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNTech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBNTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BNTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads BioNTech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.42-$1.81-$2.62Q2 20252-$3.50-$2.30-$2.90Q3 20252$0.26$2.20$1.23Q4 20252$0.19$1.85$1.02FY 20258($6.47)($0.06)($3.27) Remove Ads BioNTech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------3/10/2025Q4 2024$0.38$1.08+$0.70$1.15$1.24B$1.19B11/4/2024Q3 2024-$1.26$0.81+$2.07$0.89$514.08M$1.24B8/5/2024Q2 2024-$2.02-$3.36 -$1.34-$3.62$134.98M$128.70M5/6/2024Q1 2024-$0.82-$1.42 -$0.60-$1.42$589.96M$203.69M3/20/2024Q4 2023$2.64$2.05 -$0.59$2.05$2.04B$1.59B11/6/2023Q3 2023-$0.59$0.67+$1.26$0.73$850.50M$895.30M8/7/2023Q2 2023-$0.83-$0.79+$0.04-$0.86$628.13M$167.70M5/8/2023Q1 2023$0.18$2.05+$1.87$2.20$1.09B$1.28B3/27/2023Q4 2022$8.04$9.26+$1.22$9.46$3.87B$4.28B BioNTech Earnings - Frequently Asked Questions When is BioNTech's earnings date? BioNTech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on BNTX's earnings history. What guidance has BioNTech issued on next quarter's earnings? BioNTech updated its FY 2025 earnings guidance on Monday, March, 10th. The company issued revenue guidance of $1.8 billion-$2.3 billion, compared to the consensus revenue estimate of $2.5 billion. Did BioNTech beat their earnings estimates last quarter? In the previous quarter, BioNTech (NASDAQ:BNTX) reported $1.08 earnings per share (EPS) to beat the analysts' consensus estimate of $0.38 by $0.70. Learn more on analysts' earnings estimate vs. BNTX's actual earnings. How can I listen to BioNTech's earnings conference call? The conference call for BioNTech's latest earnings report can be listened to online. Listen to Conference Call How can I read BioNTech's conference call transcript? The conference call transcript for BioNTech's latest earnings report can be read online. Read Transcript How much revenue does BioNTech generate each year? BioNTech (NASDAQ:BNTX) has a recorded annual revenue of $2.75 billion. How much profit does BioNTech generate each year? BioNTech (NASDAQ:BNTX) has a recorded net income of $1.01 billion. BNTX has generated -$3.00 earnings per share over the last four quarters. What is BioNTech's EPS forecast for next year? BioNTech's earnings are expected to decrease from ($3.88) per share to ($4.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies GSK Earnings Date TAK Earnings Date ARGX Earnings Date ONC Earnings Date TEVA Earnings Date SMMT Earnings Date ITCI Earnings Date MRNA Earnings Date GMAB Earnings Date RDY Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:BNTX) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
